Whalerock Point Partners, LLC Bristol Myers Squibb CO Transaction History

Whalerock Point Partners, LLC

  • $414 Million
  • Q4 2024

A detailed history of Whalerock Point Partners, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Whalerock Point Partners, LLC holds 6,146 shares of BMY stock, worth $361,999. This represents 0.08% of its overall portfolio holdings.

Number of Shares
6,146
Previous 6,382 3.7%
Holding current value
$361,999
Previous $330,000 5.15%
% of portfolio
0.08%
Previous 0.08%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$51.92 - $59.94 $12,253 - $14,145
-236 Reduced 3.7%
6,146 $347,000
Q3 2024

Nov 13, 2024
SELL
$39.66 - $51.75 $5,948 - $7,762
-150 Reduced 2.3%
6,382 $330,000
Q2 2024

Aug 13, 2024
SELL
$40.25 - $52.99 $213,325 - $280,847
-5,300 Reduced 44.79%
6,532 $271,000
Q1 2024

May 15, 2024
SELL
$47.98 - $54.4 $6,909 - $7,833
-144 Reduced 1.2%
11,832 $641,000
Q4 2023

Feb 14, 2024
SELL
$48.48 - $57.85 $105,250 - $125,592
-2,171 Reduced 15.35%
11,976 $614,000
Q2 2023

Aug 14, 2023
BUY
$63.71 - $70.74 $15,991 - $17,755
251 Added 1.81%
14,147 $904,000
Q4 2022

Feb 13, 2023
SELL
$68.48 - $81.09 $958 - $1,135
-14 Reduced 0.1%
13,896 $999,000
Q3 2022

Nov 16, 2022
BUY
$0.13 - $76.84 $1,679 - $992,849
12,921 Added 1306.47%
13,910 $989,000
Q3 2022

Nov 15, 2022
SELL
$0.13 - $76.84 $1,679 - $992,849
-12,921 Reduced 92.89%
989 $989 Million
Q1 2022

May 16, 2022
SELL
$61.48 - $73.72 $27,481 - $32,952
-447 Reduced 3.11%
13,910 $1.02 Billion
Q4 2021

Feb 15, 2022
SELL
$53.63 - $62.52 $52,932 - $61,707
-987 Reduced 6.43%
14,357 $895,000
Q3 2021

Nov 12, 2021
SELL
$59.17 - $69.31 $4,319 - $5,059
-73 Reduced 0.47%
15,344 $908,000
Q2 2021

Aug 10, 2021
SELL
$61.91 - $67.42 $6,191 - $6,742
-100 Reduced 0.64%
15,417 $1.03 Billion
Q4 2020

Feb 12, 2021
BUY
$57.74 - $65.43 $842,599 - $954,819
14,593 Added 1579.33%
15,517 $963,000
Q3 2020

Nov 13, 2020
SELL
$57.43 - $63.64 $963,962 - $1.07 Million
-16,785 Reduced 94.78%
924 $55,000
Q2 2020

Aug 11, 2020
SELL
$54.82 - $64.09 $754,049 - $881,557
-13,755 Reduced 43.72%
17,709 $1.04 Million
Q1 2020

May 15, 2020
SELL
$46.4 - $67.43 $23,200 - $33,715
-500 Reduced 1.56%
31,464 $1.75 Million
Q4 2019

Feb 12, 2020
BUY
$49.21 - $64.19 $42,172 - $55,010
857 Added 2.76%
31,964 $2.05 Million
Q1 2019

May 13, 2019
BUY
$45.12 - $53.8 $27,072 - $32,280
600 Added 1.97%
31,107 $1.48 Million
Q2 2018

Mar 04, 2019
SELL
$50.53 - $62.98 $98,533 - $122,811
-1,950 Reduced 6.01%
30,507 $1.69 Million
Q4 2017

Jan 16, 2018
SELL
$59.94 - $65.35 $68,451 - $74,629
-1,142 Reduced 3.4%
32,457 $1.99 Million
Q3 2017

Oct 31, 2017
BUY
$55.23 - $63.74 $1.86 Million - $2.14 Million
33,599
33,599 $2.14 Million

Others Institutions Holding BMY

# of Institutions
2,765
Shares Held
1.56B
Call Options Held
28M
Put Options Held
28.7M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Whalerock Point Partners, LLC Portfolio

Follow Whalerock Point Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Whalerock Point Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Whalerock Point Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email